Trident Texofab Financial Statements
Quarterly
Yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 19.08 | 14.90 | 21.03 | 23.85 | 24.51 |
| Expenses | 18.37 | 14.09 | 20.11 | 22.65 | 24.09 |
| EBITDA | 0.71 | 0.81 | 0.92 | 1.20 | 0.42 |
| EBIT | 0.29 | 0.47 | 0.53 | 0.81 | 0.07 |
| Profit Before Tax | 1.17 | 0.13 | 0.27 | 0.56 | 0.30 |
| Net Profit | 0.63 | 0.15 | 0.02 | 0.15 | 0.67 |
| Financial Ratios | |||||
| Operating Profit Margin | 3.67% | 5.50% | 4.37% | 5.03% | 1.71% |
| Net Profit Margin | 3.30% | 1.01% | 0.10% | 0.63% | 2.73% |
| Earning Per Share (Diluted) | 0.60 | 0.15 | 0.04 | 0.16 | 0.61 |
| Dividends Per Share | NA | NA | NA | NA | NA |
